Literature DB >> 1853565

Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein.

J Berger1, C Aepinus, M Dobrovnik, B Fleckenstein, J Hauber, E Böhnlein.   

Abstract

HIV-1 replication depends on the expression of trans-regulatory genes (tat, rev) encoded in the 3' part of the retroviral genome. HIV-1 Rev trans-activator protein allows the cytoplasmic translocation of incompletely spliced retroviral mRNA which is required for the translational switch from regulatory (Tat, Rev, Nef) to structural proteins (Gag, Pol, Env). The HIV-1 Rev regulatory protein comprises an activation domain (RAD) and a RNA binding domain (RBD). Both functional domains are not well defined and the RBD appears to overlap with the nuclear localization signal (NLS). Our mutational analysis localized the Rev protein domain important for RRE (nucleotide 7781 to 8000) binding in vitro to amino acid residues 31 to 50. Mutations in this domain always resulted in exclusion from the nucleoli. Furthermore, these mutants did not support Rev-dependent p24 Gag production in vivo. Sequences immediately upstream of this domain (RevM4, RevM19) were attenuated in their in vivo activity possibly indicating a role in Rev protein oligomerization. The observed tight correlation between subcellular localization and RNA binding in vitro indicates that this short stretch of amino acids supports two essential functions required for HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853565     DOI: 10.1016/0042-6822(91)90992-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

Authors:  S Venkatesan; S M Gerstberger; H Park; S M Holland; Y Nam
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.

Authors:  I Weichselbraun; J Berger; M Dobrovnik; H Bogerd; R Grassmann; W C Greene; J Hauber; E Böhnlein
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies.

Authors:  Destin W Heilman; Jose G Teodoro; Michael R Green
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.

Authors:  Li-Mei Chen; Gabriel Briones; Ruben O Donis; Jorge E Galán
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat.

Authors:  Y P Li
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

Authors:  R Rosin-Arbesfeld; M Rivlin; S Noiman; P Mashiah; A Yaniv; T Miki; S R Tronick; A Gazit
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus.

Authors:  Jennifer A Mertz; Melissa S Simper; Mary M Lozano; Shelley M Payne; Jaquelin P Dudley
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

10.  Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.

Authors:  L Martarano; R Stephens; N Rice; D Derse
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.